メタ情報
| meta description平均長 | 343.72 |
|---|
| OGPありページ数 | 19 |
|---|
| Twitterカードありページ数 | 19 |
|---|
HTML言語 分布
| キー | 割合 |
|---|
| en-au | 95.00% |
| en-us | 5.00% |
内部リンク分析(Internal)
| ユニーク内部リンク数 | 309 |
|---|
| ページあたり内部リンク平均 | 119.1 |
|---|
内部リンク 深さヒストグラム
| キー | 値 |
|---|
| 0 | 39 |
| 1 | 123 |
| 2 | 199 |
| 3 | 664 |
| 4 | 1083 |
| 5 | 274 |
連絡先候補(Contacts)
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み |
|---|
| risk | 1 |
| III | 0.809524 |
| COPD | 0.773126 |
| was | 0.727164 |
| evidence | 0.671958 |
| CVD | 0.639157 |
| patients | 0.632487 |
| level | 0.619522 |
| increased | 0.60597 |
| exposure | 0.60156 |
| mortality | 0.563962 |
| associated | 0.547619 |
| were | 0.545373 |
| exacerbation | 0.545373 |
| cardiac | 0.488767 |
| smoking | 0.464577 |
| varenicline | 0.45117 |
| heart | 0.413572 |
| events | 0.413572 |
| cohort | 0.404576 |
| studies | 0.382767 |
| smokers | 0.380952 |
| medication | 0.375975 |
| adherence | 0.375975 |
| years | 0.375677 |
| study | 0.363582 |
| group | 0.363582 |
| lung | 0.357143 |
| support | 0.357143 |
| found | 0.343383 |
| groups | 0.338377 |
| disease | 0.329391 |
| analysis | 0.323184 |
| after | 0.317881 |
| history | 0.309524 |
| FEV | 0.309524 |
| reported | 0.302985 |
| stable | 0.30078 |
| sputum | 0.288983 |
| care | 0.288983 |
| days | 0.288983 |
| also | 0.287095 |
| compared | 0.282786 |
| more | 0.276688 |
| been | 0.263513 |
| dust | 0.263182 |
| results | 0.263182 |
| factors | 0.262587 |
| function | 0.261905 |
| exacerbations | 0.260977 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| New | Zealand | 4.1507 | 108 |
| Chronic | Obstructive | 4.016266 | 96 |
| HONcode | comply | 3.884855 | 76 |
| evidence | level | 3.856689 | 151 |
| Obstructive | Pulmonary | 3.843588 | 92 |
| Disease | Pulmonary | 3.843588 | 92 |
| Australian | New | 3.841073 | 92 |
| HONcode | standard | 3.69736 | 76 |
| standard | trustworthy | 3.69736 | 76 |
| health | trustworthy | 3.679474 | 76 |
| III | level | 3.622613 | 116 |
| Guidelines | Zealand | 3.503292 | 84 |
| Chronic | management | 3.433764 | 84 |
| information | trustworthy | 3.390451 | 57 |
| Guidelines | management | 3.389787 | 84 |
| Disease | Obstructive | 3.286528 | 75 |
| Foundation | Lung | 3.247809 | 44 |
| health | information | 3.21071 | 57 |
| information | verify | 3.187405 | 38 |
| HONcode | trustworthy | 3.140962 | 57 |
| Chronic | Pulmonary | 3.120048 | 69 |
| Australian | Zealand | 3.077707 | 69 |
| function | lung | 2.990776 | 40 |
| Australia | Foundation | 2.987786 | 41 |
| trustworthy | verify | 2.980864 | 38 |
| comply | standard | 2.976874 | 57 |
| airflow | limitation | 2.95563 | 32 |
| III | evidence | 2.933983 | 99 |
| Chronic | Guidelines | 2.905494 | 63 |
| health | verify | 2.832065 | 38 |
| cross | sectional | 2.8001 | 20 |
| health | standard | 2.797133 | 57 |
| Guidelines | New | 2.794457 | 63 |
| adherence | medication | 2.727852 | 30 |
| groups | support | 2.713626 | 32 |
| Obstructive | management | 2.695131 | 63 |
| Zealand | management | 2.690724 | 65 |
| analysis | meta | 2.546526 | 28 |
| disease | heart | 2.53132 | 38 |
| LABA | LAMA | 2.49974 | 15 |
| life | quality | 2.473643 | 24 |
| review | systematic | 2.459921 | 23 |
| Australia | Lung | 2.43361 | 32 |
| information | standard | 2.417495 | 39 |
| arterial | stiffness | 2.395854 | 16 |
| BNP | pro | 2.376359 | 12 |
| call | free | 2.376359 | 12 |
| Activity | Number | 2.376359 | 12 |
| CPD | accredited | 2.376359 | 12 |
| expiratory | flow | 2.340323 | 16 |